BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 34465342)

  • 21. Clinical and Pathological Characteristics of Patients With Papillary Thyroid Carcinoma Coexisting With Hashimoto's Thyroiditis: A Retrospective Cohort Study.
    Yang Y; Liu J; Shi X; Wang M
    Cancer Control; 2023; 30():10732748231199647. PubMed ID: 37643366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hashimoto's thyroiditis and papillary thyroid carcinoma. Are cytokeratin 19 and P63 proteins of any diagnostic value?
    Divani SN; Kalodimos GP; Lioupis MA; Syrmos NC
    Hell J Nucl Med; 2016; 19(3):250-253. PubMed ID: 27824965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clonal Distribution and Intratumor Heterogeneity of the TCR Repertoire in Papillary Thyroid Cancer With or Without Coexistent Hashimoto's Thyroiditis.
    Cui L; Zhang C; Ding H; Feng D; Huang H; Lu Z; Liu B
    Front Immunol; 2022; 13():821601. PubMed ID: 35720279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperatively Predicting the Central Lymph Node Metastasis for Papillary Thyroid Cancer Patients With Hashimoto's Thyroiditis.
    Min Y; Huang Y; Wei M; Wei X; Chen H; Wang X; Chen J; Xiang K; Feng Y; Yin G
    Front Endocrinol (Lausanne); 2021; 12():713475. PubMed ID: 34367075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between Hashimoto's thyroiditis and papillary thyroid carcinoma: a retrospective analysis of 305 patients.
    Graceffa G; Patrone R; Vieni S; Campanella S; Calamia S; Laise I; Conzo G; Latteri M; Cipolla C
    BMC Endocr Disord; 2019 May; 19(Suppl 1):26. PubMed ID: 31142293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyroglobulin antibodies could be a potential predictive marker for papillary thyroid carcinoma.
    Vasileiadis I; Boutzios G; Charitoudis G; Koukoulioti E; Karatzas T
    Ann Surg Oncol; 2014 Aug; 21(8):2725-32. PubMed ID: 24595799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The study of the coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma.
    Zhang Y; Dai J; Wu T; Yang N; Yin Z
    J Cancer Res Clin Oncol; 2014 Jun; 140(6):1021-6. PubMed ID: 24619663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical features of papillary thyroid cancer in Hashimoto's thyroiditis patients from an area with a high prevalence of Hashimoto's disease.
    Zhang L; Li H; Ji QH; Zhu YX; Wang ZY; Wang Y; Huang CP; Shen Q; Li DS; Wu Y
    BMC Cancer; 2012 Dec; 12():610. PubMed ID: 23256514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotypical analysis of lymphocytes with suppressive and regulatory properties (Tregs) and NK cells in the papillary carcinoma of thyroid.
    Gogali F; Paterakis G; Rassidakis GZ; Kaltsas G; Liakou CI; Gousis P; Neonakis E; Manoussakis MN; Liapi C
    J Clin Endocrinol Metab; 2012 May; 97(5):1474-82. PubMed ID: 22399513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of the Impact of Hashimoto Thyroiditis on Papillary Thyroid Carcinoma Progression: Relationship with the Tumor Immune Microenvironment.
    Sulaieva O; Chernenko O; Selesnov O; Nechay O; Maievskyi O; Falalyeyeva T; Kobyliak N; Tsyryuk O; Penchuk Y; Shapochka D
    Endocrinol Metab (Seoul); 2020 Jun; 35(2):443-455. PubMed ID: 32615729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High TPOAb Levels (>1300 IU/mL) Indicate Multifocal PTC in Hashimoto's Thyroiditis Patients and Support Total Thyroidectomy.
    Dong S; Xia Q; Wu YJ
    Otolaryngol Head Neck Surg; 2015 Jul; 153(1):20-6. PubMed ID: 25917667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological characterization and prognostic implication of FOXP3 and CK19 expression in papillary thyroid carcinoma and concomitant Hashimoto's thyroiditis.
    Mohamed SY; Ibrahim TR; Elbasateeny SS; Abdelaziz LA; Farouk S; Yassin MA; Embaby A
    Sci Rep; 2020 Jun; 10(1):10651. PubMed ID: 32606302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hashimoto's thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis.
    Lun Y; Wu X; Xia Q; Han Y; Zhang X; Liu Z; Wang F; Duan Z; Xin S; Zhang J
    Otolaryngol Head Neck Surg; 2013 Mar; 148(3):396-402. PubMed ID: 23300224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High prevalence of papillary thyroid carcinoma in nodular Hashimoto's thyroiditis at the first diagnosis and during the follow-up.
    Boi F; Pani F; Calò PG; Lai ML; Mariotti S
    J Endocrinol Invest; 2018 Apr; 41(4):395-402. PubMed ID: 28875268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymph node metastasis of papillary thyroid carcinoma in the context of Hashimoto's thyroiditis.
    Wang L; Chen J; Yuan X; Wang J; Sun L; Jiang J; Zhang L; Liu M; Zhou Q
    BMC Endocr Disord; 2022 Jan; 22(1):12. PubMed ID: 34986823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteomics and Organoid Culture Reveal the Underlying Pathogenesis of Hashimoto's Thyroiditis.
    Xiao H; Liang J; Liu S; Zhang Q; Xie F; Kong X; Guo S; Wang R; Fu R; Ye Z; Li Y; Zhang S; Zhang L; Kaudimba KK; Wang R; Kong X; Zhao B; Zheng X; Liu T
    Front Immunol; 2021; 12():784975. PubMed ID: 34925365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin.
    Latrofa F; Ricci D; Montanelli L; Rocchi R; Piaggi P; Sisti E; Grasso L; Basolo F; Ugolini C; Pinchera A; Vitti P
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2380-7. PubMed ID: 22539585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Hashimotoas thyroiditis on clinicopathologic features of papillary thyroid carcinoma associated with infiltration of tumor-infiltrating lymphocytes.
    Wang L; Li W; Ye H; Niu L
    Int J Clin Exp Pathol; 2018; 11(5):2768-2775. PubMed ID: 31938394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Underestimated Impact of Hashimoto Thyroiditis on Thyroid Papillary Carcinoma.
    Harmantepe AT; Ozdemir K; Bayhan Z; Kocer B
    Updates Surg; 2024 Jun; 76(3):1085-1089. PubMed ID: 38687448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD3(-)CD16(-)CD56(bright) immunoregulatory NK cells are increased in the tumor microenvironment and inversely correlate with advanced stages in patients with papillary thyroid cancer.
    Gogali F; Paterakis G; Rassidakis GZ; Liakou CI; Liapi C
    Thyroid; 2013 Dec; 23(12):1561-8. PubMed ID: 23721357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.